{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:25:23Z","timestamp":1794947123900,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Poor responders to ovarian stimulation are one of the most challenging populations to treat. As a failed cycle can cause a considerable emotional and economical loss, adequate fertility counseling addressing patients\u2019 expectations are highly important when facing patients with poor ovarian response. The study aimed to evaluate reproductive outcomes and to identify factors associated with live birth (LB) after fresh autologous IVF\/intracytoplasmic sperm injection (ICSI) cycles of patients fulfilling the Bologna criteria for poor ovarian response (POR).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study included 751 IVF\/ICSI treatment cycles which yielded up to three retrieved oocytes, at a tertiary referral hospital between January 2016 and February 2020. A logistic regression analysis was used to adjust for confounders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Clinical pregnancy and LB rate per cycle were significantly higher among women younger versus older than 40\u00a0years (9.8% and 6.8% vs 4.5% and 2.1%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01, respectively). Patients who achieved LB were significantly younger, had higher number of oocytes retrieved, fertilization rate and top-quality embryos (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Multivariable regression analysis identified patient\u2019s age (OR 0.90; 95% CI 0.845\u20130.97; <jats:italic>p<\/jats:italic>\u2009=\u20090.005) and mean number retrieved oocytes (OR 1.95; 95% CI 1.20\u20133.16; <jats:italic>p<\/jats:italic>\u2009=\u20090.007) as factors significantly associated with the probability of a LB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The woman\u2019s age and the number of retrieved oocytes are both independent predicting factors of live birth in poor ovarian responders. Considering the risks, the high financial investment and poor reproductive outcomes involved in IVF treatments, raises questions regarding the adequacy of providing treatments in these patients' population. POR younger than 40\u00a0years may represent a possible exception due to acceptable probability for a LB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-022-01964-y","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T07:02:59Z","timestamp":1664521379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Predicting IVF outcome in poor ovarian responders"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1171-110X","authenticated-orcid":false,"given":"Oshrit","family":"Lebovitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigal","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitzan","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Zilberberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adva","family":"Aizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kirshenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravit","family":"Nahum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"issue":"2","key":"1964_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1210\/er.2005-0015","volume":"27","author":"NS Macklon","year":"2006","unstructured":"Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27(2):170\u2013207.","journal-title":"Endocr Rev"},{"issue":"7","key":"1964_CR2","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","volume":"26","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26(7):1768\u201374.","journal-title":"Hum Reprod"},{"issue":"7","key":"1964_CR3","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","journal-title":"Hum Reprod"},{"issue":"5","key":"1964_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1471-0528.1997.tb11525.x","volume":"104","author":"SD Keay","year":"1997","unstructured":"Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol. 1997;104(5):521\u20137.","journal-title":"Br J Obstet Gynaecol"},{"key":"1964_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/352098","volume":"2014","author":"F Ubaldi","year":"2014","unstructured":"Ubaldi F, Vaiarelli A, D\u2019Anna R, Rienzi L. Management of poor responders in IVF: is there anything new? Biomed Res Int. 2014;2014: 352098.","journal-title":"Biomed Res Int"},{"issue":"7","key":"1964_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1023\/A:1009465324197","volume":"17","author":"SJ Fasouliotis","year":"2000","unstructured":"Fasouliotis SJ, Simon A, Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet. 2000;17(7):357\u201373.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"1964_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.fertnstert.2004.07.963","volume":"83","author":"KA Mohamed","year":"2005","unstructured":"Mohamed KA, Davies WA, Allsopp J, Lashen H. Agonist, \u201cflare-up\u201d versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril. 2005;83(2):331\u20135.","journal-title":"Fertil Steril"},{"issue":"4","key":"1964_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000508875","volume":"85","author":"R Orvieto","year":"2020","unstructured":"Orvieto R, Kirshenbaum M, Galiano V, Zilberberg E, Haas J, Nahum R. Stop GnRH-agonist combined with multiple-dose GnRH-antagonist for patients with elevated peak serum progesterone levels undergoing ovarian stimulation for IVF: a proof of concept. Gynecol Obstet Invest. 2020;85(4):357\u201361.","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"1964_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/09513599409023632","volume":"8","author":"Z Ben-Rafael","year":"1994","unstructured":"Ben-Rafael Z, Orvieto R, Feldberg D. The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program. Gynecol Endocrinol. 1994;8(4):277\u201386.","journal-title":"Gynecol Endocrinol"},{"key":"1964_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-015-0187-6","volume":"8","author":"R Orvieto","year":"2015","unstructured":"Orvieto R. Triggering final follicular maturation\u2013hCG, GnRH-agonist or both, when and to whom? J Ovarian Res. 2015;8:60.","journal-title":"J Ovarian Res"},{"issue":"7","key":"1964_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/BF02744937","volume":"15","author":"A Simon","year":"1998","unstructured":"Simon A, Holzer H, Hurwitz A, Revel A, Zentner BS, Lossos F, et al. Comparison of cryopreservation outcome following intracytoplasmic sperm injection and conventional in vitro fertilization. J Assist Reprod Genet. 1998;15(7):431\u20137.","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"1964_CR12","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/humrep\/dem221","volume":"22","author":"S Ziebe","year":"2007","unstructured":"Ziebe S, Lundin K, Janssens R, Helmgaard L, Arce JC, Group M. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod. 2007;22(9):2404\u201313.","journal-title":"Hum Reprod"},{"issue":"10","key":"1964_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046544","volume":"7","author":"PD Sozou","year":"2012","unstructured":"Sozou PD, Hartshorne GM. Time to pregnancy: a computational method for using the duration of non-conception for predicting conception. PLoS ONE. 2012;7(10): e46544.","journal-title":"PLoS ONE"},{"issue":"7","key":"1964_CR14","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/humrep\/dex096","volume":"32","author":"SS Malchau","year":"2017","unstructured":"Malchau SS, Henningsen AA, Loft A, Rasmussen S, Forman J, Nyboe Andersen A, et al. The long-term prognosis for live birth in couples initiating fertility treatments. Hum Reprod. 2017;32(7):1439\u201349.","journal-title":"Hum Reprod"},{"issue":"1","key":"1964_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmr037","volume":"18","author":"JF Oudendijk","year":"2012","unstructured":"Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL. The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update. 2012;18(1):1\u201311.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"1964_CR16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.fertnstert.2003.10.030","volume":"81","author":"ER Klinkert","year":"2004","unstructured":"Klinkert ER, Broekmans FJ, Looman CW, Te Velde ER. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril. 2004;81(5):1247\u201353.","journal-title":"Fertil Steril"},{"issue":"3","key":"1964_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/humrep\/deh674","volume":"20","author":"J Penarrubia","year":"2005","unstructured":"Penarrubia J, Fabregues F, Manau D, Creus M, Carmona F, Casamitjana R, et al. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod. 2005;20(3):622\u20138.","journal-title":"Hum Reprod"},{"issue":"4","key":"1964_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/14737167.2021.1910026","volume":"21","author":"M Sprem Goldstajn","year":"2021","unstructured":"Sprem Goldstajn M, Mikus M, Coric M, Oreskovic S, Dumancic S, Noventa M, et al. The pharmacoeconomic impact of follitropin alpha biosimilars in IVF therapy in Europe: a report of the literature. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):553\u20138.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"1964_CR19","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1093\/humrep\/15.11.2341","volume":"15","author":"M Creus","year":"2000","unstructured":"Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod. 2000;15(11):2341\u20136.","journal-title":"Hum Reprod"},{"issue":"1","key":"1964_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","volume":"19","author":"SL Broer","year":"2013","unstructured":"Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19(1):26\u201336.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"1964_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/humupd\/dmq015","volume":"16","author":"LL van Loendersloot","year":"2010","unstructured":"van Loendersloot LL, van Wely M, Limpens J, Bossuyt PM, Repping S, van der Veen F. Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Hum Reprod Update. 2010;16(6):577\u201389.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"1964_CR22","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0015-0282(98)00079-X","volume":"69","author":"J Hanoch","year":"1998","unstructured":"Hanoch J, Lavy Y, Holzer H, Hurwitz A, Simon A, Revel A, et al. Young low responders protected from untoward effects of reduced ovarian response. Fertil Steril. 1998;69(6):1001\u20134.","journal-title":"Fertil Steril"},{"issue":"8754","key":"1964_CR23","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/0140-6736(91)93060-M","volume":"337","author":"D Navot","year":"1991","unstructured":"Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet. 1991;337(8754):1375\u20137.","journal-title":"Lancet"},{"issue":"5","key":"1964_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1210\/er.2009-0006","volume":"30","author":"FJ Broekmans","year":"2009","unstructured":"Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5):465\u201393.","journal-title":"Endocr Rev"},{"key":"1964_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fendo.2018.00327","volume":"9","author":"D Cimadomo","year":"2018","unstructured":"Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol (Lausanne). 2018;9:327.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1964_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1023\/B:JARG.0000027018.02425.15","volume":"21","author":"AK Bartmann","year":"2004","unstructured":"Bartmann AK, Romao GS, Ramos Eda S, Ferriani RA. Why do older women have poor implantation rates? A possible role of the mitochondria. J Assist Reprod Genet. 2004;21(3):79\u201383.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"1964_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1095\/biolreprod.103.015784","volume":"70","author":"JP de Bruin","year":"2004","unstructured":"de Bruin JP, Dorland M, Spek ER, Posthuma G, van Haaften M, Looman CW, et al. Age-related changes in the ultrastructure of the resting follicle pool in human ovaries. Biol Reprod. 2004;70(2):419\u201324.","journal-title":"Biol Reprod"},{"issue":"2","key":"1964_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.fertnstert.2014.04.026","volume":"102","author":"M Vega","year":"2014","unstructured":"Vega M, Breborowicz A, Moshier EL, McGovern PG, Keltz MD. Blastulation rates decline in a linear fashion from euploid to aneuploid embryos with single versus multiple chromosomal errors. Fertil Steril. 2014;102(2):394\u20138.","journal-title":"Fertil Steril"},{"issue":"2","key":"1964_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/humrep\/12.2.241","volume":"12","author":"J Farhi","year":"1997","unstructured":"Farhi J, Homburg R, Ferber A, Orvieto R, Ben RZ. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod. 1997;12(2):241\u20133.","journal-title":"Hum Reprod"},{"issue":"8","key":"1964_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1177\/1933719116630419","volume":"23","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Conforti A, Caprio F, Gizzo S, Noventa M, Strina I, et al. In estimated good prognosis patients could unexpected \u201chyporesponse\u201d to controlled ovarian stimulation be related to genetic polymorphisms of FSH receptor? Reprod Sci. 2016;23(8):1103\u20138.","journal-title":"Reprod Sci"},{"issue":"8","key":"1964_CR31","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/humrep\/dey238","volume":"33","author":"SJ Morin","year":"2018","unstructured":"Morin SJ, Patounakis G, Juneau CR, Neal SA, Scott RT, Seli E. Diminished ovarian reserve and poor response to stimulation in patients < 38 years old: a quantitative but not qualitative reduction in performance. Hum Reprod. 2018;33(8):1489\u201398.","journal-title":"Hum Reprod"},{"issue":"4","key":"1964_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.rbmo.2013.11.010","volume":"28","author":"NP Polyzos","year":"2014","unstructured":"Polyzos NP, Nwoye M, Corona R, Blockeel C, Stoop D, Haentjens P, et al. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF\/ICSI. Reprod Biomed Online. 2014;28(4):469\u201374.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"1964_CR33","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.fertnstert.2011.09.048","volume":"96","author":"NP Polyzos","year":"2011","unstructured":"Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril. 2011;96(5):1058\u201361.","journal-title":"Fertil Steril"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01964-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01964-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01964-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T07:03:49Z","timestamp":1664521429000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01964-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01964-y","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"7 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Broad at Sheba Medical Center according to the principles of the Declaration of Helsinki (study reference number 6978-20-SMC). All methods were carried out in accordance with relevant guidelines and regulations. As a retrospective study, informed consent was exempted by the ethics committee of Sheba Medical Center. Patients\u2019 data were used anonymously.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"395"}}